Provided by Tiger Trade Technology Pte. Ltd.

JW THERAP-B

2.015
+0.1709.21%
Volume:1.17M
Turnover:2.34M
Market Cap:840.26M
PE:-1.29
High:2.055
Open:1.900
Low:1.900
Close:1.845
52wk High:6.100
52wk Low:1.400
Shares:417.00M
HK Float Shares:417.00M
Volume Ratio:1.44
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.564
ROE:-64.37%
ROA:-11.43%
PB:1.29
PE(LYR):-1.29
PS:2.54

Loading ...

JW Therapeutics to Review 2026 Interim Results on 27 August

Bulletin Express
·
Aug 12

JW Cayman Therapeutics Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 12

JW Therapeutics: No Share Capital Changes in July; 22.77 Million Options Outstanding

Bulletin Express
·
Aug 05

JW Therapeutics: June 2026 Return Shows Stable 416.73 Million Share Base and Sufficient Public Float

Bulletin Express
·
Jul 06

JW Cayman Therapeutics Files Directors List with Hong Kong Exchange

Reuters
·
Jun 26

JW THERAP-B Appoints Tian Feng as Chairman

Stock News
·
Jun 26

JW Cayman Therapeutics Names CEO Feng Tian Chairman After Cheng Liu Retires from Board

Reuters
·
Jun 26

JW Therapeutics Keeps Share Count Unchanged in May 2026; 23.07 Million Options Remain Outstanding

Bulletin Express
·
Jun 03

Market Chatter: 'Business as Usual' for China Drugmakers Despite Scrutiny of Cross-Border Tech Deals, JW Therapeutics CEO Says

MT Newswires Live
·
May 27

JW THERAP-B Sets 26 June 2026 AGM to Vote on FY2025 Results, Director Slate, Auditor Re-appointment and Share Mandates

Bulletin Express
·
May 26

JW Therapeutics Grants 2.00 Million Share Options to CEO Feng Tian at HK$2.32 Exercise Price

Bulletin Express
·
May 19

JW THERAP-B (02126) Grants 2 Million Share Options

Stock News
·
May 19

JW THERAP-B Issues 0.26 Million New Shares in April; Outstanding Options Rise to 21.07 Million

Bulletin Express
·
May 07

JW THERAP-B 2025 ESG Report: Governance Strength, Drug Innovation and Carbon-Cut Wins Spotlight

Bulletin Express
·
Apr 28

JW THERAP-B:2025年营收达2.837亿元,同比增长79.3%,核心产品销售与许可收入双驱动业绩提升

Bulletin Express
·
Apr 28

JW Cayman Therapeutics publishes 2025 annual report

Reuters
·
Apr 28

JW THERAP-B (02126) Awards 8.04 Million Share Options and 220,000 Restricted Share Units

Stock News
·
Apr 20

JW Cayman Therapeutics grants 8,040,000 share options at HK$ 2.52 per share

Reuters
·
Apr 20

JW Therapeutics files March 2026 equity return: share count unchanged at 416.47 million; 13.59 million options outstanding

Bulletin Express
·
Apr 08

JW Cayman Therapeutics SEHK 2126 Loss Of C¥267m Tests Bullish Growth Narratives

Simply Wall St.
·
Mar 28